Series A Genetics Companies

Kuehnle Agrosystems is involved in biotech research and development of plant-based systems for producing biologically active compounds.

GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.

BioCentriq is a cell and gene therapy development and manufacturing center.

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

Pow.bio provides a genetically engineered solution for fermentation scientists.

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.

AEENA Dx is developing a saliva-based platform for the detection of cancer and other diseases

RheumaGen develops a class of cell and gene therapy treatments aimed at autoimmune diseases.

Protillion Biosciences specializes in the design and development of protein-based drugs.

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

A comprehensive platform and product suite for advanced therapeutics.

MicroByre is a biotechnology company that specializes in microbiology, synthetic biology, molecular biology, and machine learning..

iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.

Industrial-scale genome sequencing

Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases